SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258

Detalles Bibliográficos
Autores principales: Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de rhumatologie. Published by Elsevier Masson SAS. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480129/
https://www.ncbi.nlm.nih.gov/pubmed/34600149
http://dx.doi.org/10.1016/j.jbspin.2021.105281
_version_ 1784576410344488960
author Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_facet Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_sort Mungmunpuntipantip, Rujittika
collection PubMed
description
format Online
Article
Text
id pubmed-8480129
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Société française de rhumatologie. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-84801292021-09-30 SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258 Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Joint Bone Spine Correspondence Société française de rhumatologie. Published by Elsevier Masson SAS. 2022-01 2021-09-29 /pmc/articles/PMC8480129/ /pubmed/34600149 http://dx.doi.org/10.1016/j.jbspin.2021.105281 Text en © 2021 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
title SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
title_full SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
title_fullStr SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
title_full_unstemmed SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
title_short SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
title_sort sars cov-2 vaccine and rituximab. comment on: “sars cov-2 vaccine and rituximab, timing is probably a key for a better vaccine response” by verhoeven joint bone spine. 2021;88:105258
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480129/
https://www.ncbi.nlm.nih.gov/pubmed/34600149
http://dx.doi.org/10.1016/j.jbspin.2021.105281
work_keys_str_mv AT mungmunpuntipantiprujittika sarscov2vaccineandrituximabcommentonsarscov2vaccineandrituximabtimingisprobablyakeyforabettervaccineresponsebyverhoevenjointbonespine202188105258
AT wiwanitkitviroj sarscov2vaccineandrituximabcommentonsarscov2vaccineandrituximabtimingisprobablyakeyforabettervaccineresponsebyverhoevenjointbonespine202188105258

Ejemplares similares